Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury

Circulation

Volumn 96, Issue 8, 1997, Pages 2641-2648

  Lipshultz, Steven E ^a,d,f   Rifai, Nader ^a,d   Sallan, Stephen E ^a,d   Lipsitz, Stuart R ^c   Dalton, Virginia ^g   Sacks, David B ^b,d   Ottlinger, Michael E ^e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g NONE

Author keywords

Heart defects, congenital; Myocardial infarction; Pediatrics doxorubicin; Troponin T

Indexed keywords

DOXORUBICIN; TROPONIN T;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CORONARY RISK; DISEASE SEVERITY; HEART DILATATION; HEART INFARCTION; HEART MUSCLE INJURY; HEART SURGERY; HUMAN; INFANT; NEWBORN; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030853573     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2641     Document Type: Article

References (33)

1. Omokhodion SI, Losekoot TG, Jaiyesimi F. Serum creatine kinase and creatine kinase-MB isoenzyme activities in perinatally asphyxiated newborns. Eur Heart J. 1991;12:980-984.
2. Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, Orav EJ, Gelber RD, Colan SD. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995;332:1738-1743.
3. Hanna B, Colan SD, Bridges ND, Mayer JE, Castaneda A. Clinical and myocardial status after left ventriculotomy for ventricular septal defect closure. J Am Coll Cardiol. 1991;17:110A. Abstract.
4. Boutin C, Wernovsky G, Sanders SP, Jonas RA, Castaneda AR, Colan SD. Rapid two-stage arterial switch operation: evaluation of left ventricular systolic mechanics late after an acute pressure overload stimulus in infancy. Circulation. 1994;90:1294-1303.
5. Gerhardt W, Katus H, Ravkilde J, Hamm C, Jorgensen PJ, Peheim E, Ljungdahl L, Lofdahl P. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem. 1991;37:1405-1411.
6. Karim MA, Shinn MS, Oskarsson H, Windle J, Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1995;76:521-523.
7. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE Jr, Califf RM, Topol EJ, GUSTO IIa Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333-1341.
8. Omura T, Teragaki M, Tani T, Yamagishi H, Yanagi S, Nishikimi T, Yoshiyama M, Toda I, Akioka K, Takeuchi K, Takeda T. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J. 1993;57: 1062-1070.
9. Burlina A, Zaninotto M, Secchiero S, Rubin D, Accorsi F. Troponin T as a marker of ischemic myocardial injury. Clin Biochem. 1994;27:113-121.
10. Grant JW, Canter CE, Spray TL, Landt Y, Saffitz JE, Ladenson JH, Jaffe AS. Elevated donor cardiac troponin I: a marker of acute graft failure in infant heart recipients. Circulation. 1994;90:2618-2621.
11. Fink FM, Genser N, Fink C, Falk M, Mair J, Maurer-Dengg K, Hammerer I, Puschendorf B. Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy. Med Pediatr Oncol. 1995;25:185-189.
12. Ottlinger ME, Sallan SE, Rifai N, Sacks D, Lipshultz SE. Myocardial damage in doxorubicin-treated children: a study of serum cardiac troponin-T. Proc Am Soc Clin Oncol. 1995;14:345. Abstract.
13. Taggart DP, Hadjinikolas L, Wong K, Yap J, Hooper J, Kemp M, Hue D, Yacoub M, Lincoln JC. Vulnerability of paediatric myocardium to cardiac surgery. Heart. 1996;76:214-217.
14. Hirsch R, Dent CL, Wood MK, Huddleston CB, Mendeloff EN, Landt Y, Landt M, Ladenson JH, Canter CE. Patterns and predictive value of elevation of cardiac troponin-I after cardiothoracic surgery in children. Circulation. 1996;94:I-480-I-481. Abstract.
15. Fischer JE, Remppis A, Ehlermann P, Schmid E, Fanconi S. Troponin-T in monitoring of myocardial injury in critically ill children. Circulation. 1996;94:I-56. Abstract.
16. Anderson PAW, Greig A, Mark TM, Malouf NN, Oakley AE, Ungerleider RM, Allen PD, Kay BK. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res. 1995;76:681-686.
17. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol. 1992; 19:619-629.
18. Katus HA, Looser S, Hallermayer K, Remppis A, Scheffold T, Borgya A, Essig U, Geuss U. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 1992;38:386-393.
19. Anderson JR, Hossein-Nia M, Brown P, Holt DW, Murday A. Donor cardiac troponin-T predicts subsequent inotrope requirements following cardiac transplantation. Transplantation. 1994;58:1056-1057.
20. Newburger JW, Jonas RA, Wernovsky G, Wypij D, Hickey PR, Kuban KCK, Farrell DM, Holmes GL, Helmers SL, Constantinou J, Carrazana E, Barlow JK, Walsh AZ, Lucius KC, Share JC, Wessel DL, Hanley FL, Mayer JE, Castaneda AR, Ware JH. A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N Engl J Med. 1993;329:1057-1064.
21. Grifka RG, Puleo PR, Perryman MB, Towbin JA. Evaluating myocardial ischemia-infarction in children after cardiac surgery using creatine kinase-MB levels. Pediatr Cardiol. 1994;15:259. Abstract.
22. Eikvar L, Pillgram-Larsen J, Skjaeggestad O, Arnesen H, Stromme JH. Serum cardio-specific troponin T after open heart surgery in patients with and without perioperative myocardial infarction. Scand J Clin Lab Invest. 1994;54:329-335.
23. Missov E, Pau B, Calzolan C. Increased circulating levels of cardiac troponin I in anthracycline-treated patients. Circulation. 1996;94: I-732. Abstract.
24. Raderer M, Kornek G, Weinlander G, Kastner J. Serum troponin T levels in adults undergoing anthracycline therapy. J Nat Cancer Inst. 1997;89:171. Letter.
25. Missov E, Calzolari C, Pau B. Increased levels of cardiac troponin I in cancer patients. J Am Coll Cardiol. 1997;129:321a. Abstract.
26. Zhang J, Herman EH, Ferrans VJ. Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187. Am J Pathol. 1993;142:1916-1926.
27. Gaudin PB, Hruban RH, Beschorner WE, Kasper EK, Olson JL, Baughman KL, Hutchins GM. Myocarditis associated with doxorubicin cardiotoxicity. Am J Clin Pathol. 1993;100:158-163.
28. Zimmermann R, Baki S, Dengler TJ, Ring GH, Remppis A, Lange R, Hagl S, Kubler W, Katus HA. Troponin T release after heart transplantation. Br Heart J. 1993;69:395-398.
29. Carrio I, Estorch M, Berna L, Germa JR, Alonso C, Ojeda B, de Andres L, Lopez-Pousa A, Martinez-Duncker C, Torres G. Assessment of anthracycline-induced myocardial damage by quantitative indium 111 myosin-specific monoclonal antibody studies. Eur J Nucl Med. 1991;18:806-812.
30. 111In monoclonal antimyosin Fab in detecting doxorubicin cardiotoxicity in rats: morphological and hemodynamic findings. Circulation. 1992;86:1065-1072.
31. Herman EH, Lipshultz SE, Rifai N, Zhang J, Papolan T, Yu Z-X, Ferrans VJ. Cardiac troponin T: elevated serum levels and loss from cardiac myocytes in doxorubicin toxicity. Circulation. 1996; 94:1-85. Abstract.
32. Seino Y, Tomita Y, Nagae Y, Kusama Y, Hayakawa H, Sasaki T, Horii I. Cardioprotective effects of ACE-inhibitor (Cilazapril) on adriamycin cardiotoxicity in spontaneously hypertensive rats. Circulation. 1993;88:I-633. Abstract.
33. Sarvazyan N. Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes. Am J Physiol. 1996;271:H2079-H2085.